Oral cladribine discontinued for MS

 

Oral cladribine will not be marketed for multiple sclerosis and the drug will be pulled in countries where it has already received approval, according to an announcement from manufacturer Merck KGaA.

It takes 30 seconds

TOPICS:
Recommend to a Colleague

Related Posts

Go back to home page